The human gene map for performance and health-related fitness phenotypes. Med. Sci. Sports Exerc., Vol. 33, No. 6, 2001, pp. 855-867. The aim of this paper is to describe the first human gene map for physical performance and health-related fitness traits based on the papers published until the end of 2000. Studies of candidate genes using case-control and other designs are reviewed. Quantitative trait loci from the limited evidence reported to date in genomic scans are also incorporated. Performance and fitness phenotypes in the sedentary state as well as their changes during exercise, if applicable, or in response to exercise training are considered. Physical performance traits include cardiorespiratory endurance indicators and muscular strength or muscular performance variables. Health-related fitness phenotypes are grouped under the following categories: hemodynamic traits; anthropometry and body composition; insulin and glucose metabolism; and lipids, lipoproteins, and hemostatic factors. A yearly update of this human gene map will be published.
T he first documented attempt to identify genetic differences for performance-related phenotypes goes back to the 1960s. A group of geneticists, taking advantage of the 1968 Mexico Olympic Games, investigated common blood genetic markers to verify whether there were differences in allele or genotype frequencies between Olympic athletes and controls (10) . The effort to document genetic differences between elite athletes and sedentary controls was continued on the occasion of the 1976 Montreal Olympic Games (8, 9) . These early attempts were all based on polymorphism in red blood cell antigens and enzymes. Later, skeletal muscle gene product variants were screened (4, 30) , and selected enzyme markers were investigated for their putative effects on a variety of skeletal muscle and cardiorespiratory endurance indicators (3) .
Genetic differences that may affect fitness or performance began to be investigated at the DNA level in the 1990s. Progress has been rather slow, particularly as a result of the inadequate training of exercise biologists in genomic technologies and their lack of enthusiasm for genetic issues. This may, however, be about to change. Pressure from the major funding agencies has already begun to force exercise biologists to incorporate genomics and other molecular biology technologies in their research if they want to remain or become competitive, particularly in light of the advances in the sequencing of the human genome (25, 61) as well as mouse and rat genomes.
We can therefore predict with confidence that the identification of the genes and related sequence variants contributing to human variation in performance and fitness will attract the attention of a growing number of exercise biologists (5) . Thus, it would seem opportune to review what has been accomplished to date and to update this review on a regular basis. This paper on the current status of the human gene map for loci associated or linked with physical performance and health-related fitness phenotypes constitutes the first of a planned yearly review. It is hoped that this first version of the human gene map for performance and healthrelated fitness will incorporate all the evidence published until the end of the year 2000. Thereafter, the yearly update of the gene map will add the data accumulated over the last calendar year. It is important to note that only published data will be incorporated in the map. Abstracts or papers in press will not be considered.
The purpose of the publication is to include all genetic loci and markers that have been shown to be or proven not to be related to physical performance or health-related fitness phenotypes. A pictogram of all chromosomes will be developed to localize all loci with evidence of a relationship with a relevant trait. It is also our goal to develop an electronic version of the Human Gene Map for Performance and Health-Related Fitness in a more elaborate form to be made available on the Journal's web site and that of the Pennington Biomedical Research Center.
The following traits have been retained for this first version of the map. All physical performance phenotypes have been considered with an emphasis on cardiorespiratory endurance and muscular strength variables. As for the healthrelated fitness domain, we have elected to use a broad definition of the traits to be covered (7) . The phenotypes have been grouped under four categories: hemodynamics; anthropometry and body composition; insulin and glucose metabolism; and lipids, lipoproteins, and hemostatic factors. It is important to note here that the evidence for a role of specific genes or DNA sequence variants on these phenotypes in a resting or unchallenged state will not be reviewed here. The focus will rather be on the acute phenotype response to exercise or the changes brought about by exercise training. The presentation will rely heavily on summary tables with no or little discussion of specific results. The original publications will be fully referenced such that the interested reader can easily access the research papers if necessary.
The evidence for a genetic contribution to human variation for each of the traits considered will not be reviewed here. In most cases, based on nuclear family and twin data, there is solid evidence for the presence of familial aggregation and of a significant genetic component. For a detailed discussion of the research supporting this generalization, the reader is referred to Bouchard et al. (5) .
Finally, this first version of the human gene map has been put together by a group of colleagues from five laboratories from around the world who have collaborated on projects pertaining to the genetics of fitness and performance for several years. As the map expands and the issues become more complex, additional collaborations will be sought to update this publication. We welcome your comments and suggestions and hope that you will find the Human Gene Map of Performance and Health-Related Fitness a useful instrument in your research and teaching.
PERFORMANCE PHENOTYPES Endurance Phenotypes
Case-control studies. Results of the studies on differences in common blood genetic markers between Olympic athletes and controls are summarized in Table 2 (see  Table 1 for the acronyms and full names of genes and Fig.  1) . A slightly higher frequency of the A1 allele of the ABO blood group was observed in endurance athletes participating in the 1976 Summer Olympic Games than in reference populations (8) . However, the other tested markers did not differ between athletes and controls (8 -10) .
The most extensively studied candidate gene thus far is the angiotensin-converting enzyme (ACE) gene (Table 3) . A greater frequency of the insertion (I) allele in the ACE locus has been reported in Australian rowers (20) , British mountaineers (35) and runners (36) , and Spanish athletes (1) than in nonathlete controls. However, in larger cohorts of elite endurance athletes (43) , Australian Olympic athletes (56) , and British Olympic athletes (36) , the allele and genotype frequencies of the I/D polymorphism did not differ from those of sedentary controls.
Significant differences have been reported in allele and genotype frequencies for an ␣2A-adrenergic receptor (ADRA2A) gene marker between elite endurance athletes and sedentary controls (64) ( Table 3 ). No differences were found between athletes and controls in angiotensin receptor 1 (AGTR1) (1, 20) and 2 (AGTR2) (20) , ␤2-adrenergic receptor (ADRB2) (64), muscle-specific creatine kinase (CKM) (47) , and mitochondrial DNA markers (49) .
Cross-sectional association studies. The studies investigating associations between endurance performance phenotypes and candidate gene markers are summarized in Table 4 . In postmenopausal women, greater maximal oxygen uptake (V O 2max ) and arterial-venous O 2 difference were reported in the ACE I/I homozygotes as compared with D-allele carriers (24) . An increasing frequency of the ACE I allele as a function of running distance was reported in British Olympic-level runners (36) . However, the significance disappeared when the analyses were repeated in white runners only. In the HERITAGE Family Study, no associations were found between the ACE I/D polymorphism and maximal and submaximal exercise V O 2 and power output phenotypes in healthy sedentary blacks and whites (41) . Genetic variants of skeletal muscle creatine kinase (CKM) and adenylate kinase (AK1) were screened for using isoelectric focusing in 295 subjects (3) . A variant form of both enzymes was identified with an allele frequency of 1% (CKM) and 3.5% (AK1). There was no difference in V O 2max between the carriers of the variant alleles and matched controls homozygous for the nonvariant allele (3). V O 2max was associated with a CKM polymorphism in middle-aged white subjects (46) , whereas no associations were found between the Na,K-ATPase ␣2 (ATP1A2) locus and V O 2max and maximal power output in the sedentary state (39) . Among 16 pairs of male twin athletes (8 monozygotic and 8 dizygotic pairs), the class I A major histocompatibility complex (HLA-A) locus was associated with V O 2max (50) . In heart failure patients, a polymorphism in the ADRB2 gene was associated with peak V O 2 (62) . In peripheral arterial occlusive disease patients with severe atherosclerotic lesions, a haptoglobin (HP) polymorphism was associated with maximal walking distance (12) . Associations of mitochondrial DNA (mtDNA) sequence variation with V O 2max were investigated in 46 young men. Three of the eight polymorphisms detected (two in the complex I, subunit ND5 (MTND5) gene and one in the threonine transfer RNA (MTTT) gene) showed significant associations with V O 2max (13) .
Association studies with training response phenotypes. In British army recruits, a significantly greater improvement in muscle efficiency (63) and repetitive elbow flexions (35) in response to exercise training has been reported in the ACE I/I homozygotes than in the D-allele carriers (Table 4 ). However, in the HERITAGE Family Study, the DD genotype among the white offspring showed the greatest endurance-training-induced improvements in maximal and submaximal power output phenotypes (41) . No associations were found with maximal and submaximal exercise V O 2 and power output training responses in white parents and in black parents and offspring. Carriers of a skeletal muscle CKM variant identified by isoelectric focusing tended to have greater V O 2max training response than the noncarriers (3). In the HERITAGE Family study cohort, a CKM polymorphism was associated with V O 2max training response in white parents and offspring (46) , and the ATP1A2 markers showed associations with V O 2max and maximal power output training responses (39) . A Hinc II polymorphism in the MTND5 gene was associated with a decreased training response in a group of healthy young male subjects (13) .
Linkage studies. The first attempt to link anonymous chromosomal markers to endurance phenotypes focused on chromosome 22 (19) . However, no significant linkages were detected for V O 2max in the sedentary state or its response to endurance training (19 on 1p11.2, 2p16.1, 4q26, 6p21.33, and 11p14.1 (6) ( Table 5) .
In candidate gene studies, markers of CKM and ATP1A2 loci have showed weak evidence of linkage with V O 2max training response (39, 48) and for ATP1A2 also with maximal power output training gain (39) .
Muscle Strength Phenotypes
Data on the associations between DNA sequence variation and muscle strength phenotypes are scarce, and the results of the available studies are summarized in Table 6 . In a large cohort of Dutch postmenopausal women, significant associations between a vitamin-D receptor (VDR) gene polymorphism and grip and quadriceps strength were reported (21) . No associations were found between the same strength phenotypes and DNA sequence variation in the estrogen receptor 1 (ESR) locus (60) . Maximal isometric forces, shortening velocities and decrease of maximal power of the adductor pollicis muscle after maximal electric activation of the ulnar nerve did not differ between six healthy controls and six patients with AMP deaminase 1 (AMPD1) deficiency who were homozygotes for the C34T mutation in the AMPD1 gene (11) . The role of the ACE I/D polymorphism in the quadriceps muscle strength responsiveness to strength training was investigated in 33 healthy male subjects. Carriers of the D allele showed significantly greater training responses than the ACE I/I homozygotes (16) . Anaerobic capacity, measured as 10-s and 90-s power output, did not differ between carriers and noncarriers of skeletal muscle CKM and AK1 variants (3). However, decline in force production of the adductor pollicis muscle during a 60-s maximum voluntary contraction tended to be less in the carriers of the variant (3). 
HEALTH-RELATED FITNESS PHENOTYPES Hemodynamic Phenotypes
Acute exercise. Studies on the associations between DNA sequence variation and exercise-related hemodynamic phenotypes have concentrated on classical hypertension candidate genes (Table 7) . A significantly higher maximal exercise diastolic blood pressure (DBP max ) (17) and postexercise (3 min) atrial natriuretic peptide (18) levels were detected in the ACE D/D homozygotes as compared with other ACE genotypes, whereas no differences were found in maximal exercise systolic blood pressure (SBP max ) and heart rate (HR max ), submaximal exercise SBP, DBP, and HR (17), or postexercise brain natriuretic peptide (BNP) levels (18) . In postmenopausal women, the ACE I/I homozygotes showed greater HR max than the D-allele carriers, whereas no differences were found in maximal cardiac output and stroke volume indexes as well as total peripheral resistance (TPR) (24) . In 19 chronic obstructive pulmonary disease patients, significantly higher mean pulmonary arterial pressure and pulmonary vascular resistance responses to acute exercise were reported in the ACE D/D homozygotes as compared with other ACE genotypes (28) . In the HERI-TAGE Family Study, no associations were found between the ACE I/D polymorphism and submaximal and maximal SBP, DBP and HR, and submaximal cardiac output and stroke volume (38, 41) .
In a small cohort of healthy young and middle-aged men, the TT homozygotes of the angiotensinogen (AGT) M235T polymorphism showed smaller DBP response to submaximal exercise than the M-allele carriers (29) ( Table 7 ). In 190 sedentary white male subjects, DBP at 50 W was not associated with the AGT M235T polymorphism, but the TT genotype showed significantly higher DBP max than the other genotypes (38) . The difference disappeared after 20 wk of endurance training. In the Glasgow Heart Scan Study, a significant association was observed between an endothelin 1 (EDN1) polymorphism and SBP max (57) . The association was particularly strong in subjects with a body mass index of 26 kg·m Ϫ2 or greater. In heart failure patients, DNA sequence variation in the ADRB2 locus was associated with cardiac index, systemic vascular resistance, and stroke volume measured during an exercise test (62) . The ATP1A2 and endothelial nitric oxide synthase (NOS3) polymorphisms did not show any associations with submaximal exercise hemodynamic phenotypes (40, 42) .
Training response. In British military recruits, the ACE D/D genotype was associated with greater increase in left ventricular (LV) mass, LV mass index, septal thickness, posterior wall thickness, and plasma BNP concentration than in other ACE genotypes after a 10-wk physical training period (33) ( Table 8 ). In Italian soccer players, the ACE D-allele carriers showed a greater increase in LV mass after a 7-month training period than the ACE I/I homozygotes (14) . However, changes in LV mass index, septal thickness, posterior wall thickness, end-systolic and end-diastolic dimensions, and ejection fraction did not differ between the ACE genotypes. None of the cardiac phenotypes were associated with an angiotensin receptor 1 (AGTR1) polymorphism in the same study (14) . In a small cohort of sedentary hypertensive men, the ACE I/D and a lipoprotein lipase (LPL) polymorphism were associated with training-induced changes in resting DBP whereas apolipoprotein E (APOE), and LPL markers showed significant associations with resting SBP responses (22) . In the HERITAGE Family Study, the ACE D/D homozygotes among white offspring showed a Table 1. greater reduction in HR at 50 W after a 20-wk endurancetraining program (41) . However, no associations were observed in white parents or black parents and offspring. Moreover, training changes of HR max and HR at 80% and 60% of V O 2max were not associated with the ACE genotype (41) .
The TT homozygotes of the M235T polymorphism showed a smaller reduction in DBP at 50 W in response to a 20-wk endurance-training program among white men than did the other AGT genotypes (38) ( Table 8 ). The ACE I/D was not associated with the training response, but a significant interaction between the AGT and ACE genotypes was found. Men, who were homozygotes for the AGT T allele and who also carried the ACE D allele, showed no DBP at 50-W training change (38) . Significant associations were also found between the NOS3 genotype and DBP and rate-pressure product (RPP) at 50-W training changes in white men and women (42) .
Anthropometry and Body Composition Phenotypes
The evidence for associations and linkages with phenotypes related to anthropometry and body composition is summarized in Table 9 . As for the other health-related fitness phenotypes, relatively few association and linkage studies have been reported for anthropometry and body composition phenotypes in response to regular exercise. The effects of the Trp64Arg mutation in the ␤3-adrenergic receptor (ADRB3) gene on changes in body mass and indicators of body fat distribution after 3 months of a lowcalorie and exercise program were investigated in 61 obese women with type 2 diabetes mellitus (51). Compared with noncarriers, carriers of the mutation were found to have smaller reductions in body weight, BMI, and waist to hip ratio (WHR). Another study involving the Gln27Glu polymorphism in the ADRB2 gene provided evidence of a gene-physical activity interaction effect. In the latter study involving 1152 men and women (31), significant interactions between the Gln27Glu polymorphism of the ADRB2 gene and various indicators of body mass and fat distribution were found in men but not in women. The ADRB2 polymorphism was found to be associated with higher body weight, BMI, waist and hip circumferences, and WHR, but only in inactive men and not in those who were physically active. The authors reported that the risk of obesity associated with the Gln27Glu polymorphism was 3.45 (P ϭ 0.002) in sedentary men compared with 1.6 (P ϭ 0.30) in active men (31) . More recently, evidence of gene-physical activity interaction was also reported between the UCP3 gene and BMI in 368 morbidly obese subjects (37) . The authors reported that a polymorphism in the 5' flanking region of the UCP3 gene was associated with BMI in a group of morbidly obese subjects and that BMI was negatively associated with physical activity but only in the subjects with the more frequent CC genotype (37) . In another report (53) , the impact of a polymorphism in the 5' region of the insulin-like growth factor (IGF1) gene and changes in body composition (assessed by underwater weighing) after 20 wk of endurance training was investigated in 502 Caucasian subjects participating in the HER-ITAGE Family Study. Results indicated significant differences in the gains of fat free mass (FFM) in response to endurance training between homozygotes for the most common allele (189 bp) of the IGF1 polymorphism compared with the heterozygotes for the 189-bp allele and noncarriers of the 189-bp allele. A strong evidence of linkage (P ϭ 0.0002; 308 sib-pairs) was also observed between the IGF1 polymorphism and training-induced changes in FFM (53) . The changes in body composition in response to exercise training were also investigated as a function of the I/D polymorphism in the ACE gene (32) . In this case, the changes in body composition were investigated in 81 British army recruits after 10 wk of physical training. Indicators of body composition included total body mass, fat mass (FM), and FFM assessed either by bioimpedance, magnetic resonance of the mid-thigh, or predicted by skinfolds measurements taken at four different sites. Results from bioimpedance data (those with the largest number of subjects, N ϭ 76) indicated that subjects with the II genotype exhibited greater changes than carriers of the D allele for total body mass, FM, and FFM. In women, increase in muscle volume in response to a strength training program was weakly associated with a myostatin (MSTN) gene polymorphism (26) , whereas no association between the MSTN genotype and muscle mass changes response to strength training was reported in another study (15) .
The other studies listed in Table 9 deal with the effects of the vitamin-D receptor (VDR) polymorphism on bone mineral density (BMD). The effect of the BsmI VDR polymorphism on the response of bone features to exercise training was investigated in 33 postmenopausal women who completed, on average, 20.4 Ϯ 3.9 min·d Ϫ1 of brisk walking over a 1-yr period and 36 controls (58) . Despite the absence of significant differences among the three VDR genotypes for percent changes in BMD in both controls and walkers, the changes in BMD were significantly different between walkers (2.3%) and controls (Ϫ6.1%) who were homozygotes for the b allele (the one with the restriction site) (58). These results suggest that bb individuals are more sensitive to regular exercise than other VDR genotypes. Another study based on the same VDR polymorphism found no significant difference among VDR genotypes for changes in BMD in 35 premenopausal women who took part in a progressive, high-impact exercise program 3 times a week for 18 months (27) . The response of bone metabolism to 1 month of weight training was also recently investigated in 
Insulin and Glucose Metabolism Phenotypes
The only evidence of gene-exercise interaction for phenotypes related to insulin and glucose metabolism comes from a study described above involving the Trp64Arg mutation in the ADRB3 gene in 61 obese women with type 2 diabetes mellitus (51) . In addition to indicators of body mass and fat distribution, the effects of a low-calorie and exercise program on fasting glucose and insulin levels, and HbA 1c levels were compared among carriers and noncarriers of the Trp64Arg mutation. The results revealed smaller reductions of fasting glucose levels (P Ͻ 0.001) and HbA 1c levels (P ϭ 0.039) in carriers compared with noncarriers, suggesting that the Trp64Arg mutation of the ADRB3 gene could be associated with improved glycemic control in obese diabetic patients in response to diet and regular exercise (51) .
Blood Lipid, Lipoprotein, and Hemostatic Factor Phenotypes
Currently available data on the associations between genetic variants and changes in blood lipids, lipoproteins, or hemostatic factors in response to regular exercise are limited to a few candidate genes (Table 10) . Two cross-sectional studies have considered the interactions between apolipoprotein E (APOE) genotypes and physical activity or physical fitness on plasma lipoprotein cholesterol levels (52, 54) . In a large cohort of adolescent boys, correlations between physical activity and serum total and low-density lipoprotein (LDL) cholesterol, as well as high-density lipoprotein (HDL)/total cholesterol ratio varied significantly across the APOE genotypes, with no correlation among APOE4 homozygotes (54) . V O 2max correlated significantly with plasma triglycerides among the APOE3 homozygotes and APOE2 carriers but not in the APOE4 carriers HF, heart failure; ANP, atrial natriuretic peptide; BNP, brain natriuretic peptide; COPD, chronic obstructive pulmonary disease; Ppa, mean pulmonary artery pressure; Rpv, Pulmonary vascular resistance; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; RPP, rate pressure product; BMI, body mass index; SV, stroke volume; Q, cardiac output.
in middle-aged men and women (52) . However, no formal fitness-genotype interaction test was performed. In middleaged and elderly men, greater HDL and HDL 2 cholesterol responses to endurance training were reported in the carriers of APOE2 allele than in APOE3 homozygotes and APOE4 carriers (23) . A cross-sectional study reported an interaction between a lipoprotein lipase (LPL) gene polymorphism and regular physical activity on plasma lipoprotein cholesterol (2). Among physically inactive, the carriers of the D9N variant showed significantly greater plasma total cholesterol and apo- lipoprotein B levels and lower HDL-cholesterol levels than the noncarriers, whereas no associations were observed among physically active subjects (2) . In a small cohort of obese, sedentary men, training-induced changes in HDL and HDL 2 cholesterol levels were associated with a LPL polymorphism (22) . An apolipoprotein AI gene polymorphism was not associated with plasma HDL cholesterol and apolipoprotein AI levels in South African marathon runners (65) . Limited genetic data have been published (Table 10 ) on exercise and hemostatic factors: one cross-sectional study (44) , one noncontrolled training study investigating both acute and chronic effects of exercise (34) , and two reports based on a controlled randomized clinical trial design (45, 59) . In postmenopausal women, a significant interaction between regular physical activity and a fibrinogen A␣ polypeptide (FGA) gene polymorphism on plasma fibrinogen levels has been reported (44) . Plasma fibrinogen response to low-intensity endurance training was not associated with the FGA genotype in middleaged men (45) . However, in the exercise group, training-induced changes in aerobic threshold and plasma fibrinogen level showed a strong inverse correlation among the Thr homozygotes (at codon 312) of the FGA gene, whereas no correlation was found in the Thr homozygotes of the control group (45) . In British military recruits, strenuous exercise-induced acute increase in plasma fibrinogen levels was associated with a fibrinogen B␤ polypeptide (FGB) gene polymorphism (34) . In middle-aged men, plasma plasminogen activator inhibitor 1 (PAI1) activity decreased significantly in an exercise training group among the homozygotes for the 4G allele of a PAI1 polymorphism, whereas the changes for the other genotypes among the exercisers and among all genotypes in the control group were nonsignificant (59).
SUMMARY AND CONCLUSIONS
It is obvious that the human gene map for physical performance and health-related fitness phenotypes is still in its infancy. Considering that we are dealing here with families of multifactorial phenotypes, it is even more obvious that little has been accomplished to date. For instance, no gene contributing to human variation in endurance performance has even been identified yet as a result of studies based on model organisms. Now that we have entered the era in which large fractions of the human, mouse, and rat genomic sequences have became available, the field of exercise science and sports medicine has a lot of catching up to do.
Expression studies in rodents and human tissues are needed to generate new and hopefully better justified candidate genes. Engineered mice through conditional knockout or transgenism are needed to define the role of specific genes and pathways and thus generate new candidate genes for testing in human studies. Genomic scans in human cohorts and informative rodent crosses followed by positional cloning are needed to evidence new candidate genes. Existing and new candidate genes need to be explored more thoroughly. This includes not only testing these genes in more appropriate human study designs but also investigating in greater detail the sequence of these genes to uncover new and perhaps more relevant polymorphisms than those reported to date.
Despite the fact that it is only a modest beginning, we hope that this yearly publication will become a useful tool for research and teaching. It would be appreciated if readers would inform us of peer-reviewed papers that were inadvertently omitted in this review. Likewise, we would welcome being notified of any new publications related to this topic. The next version of the map will cover the published literature up to the end of 2001. 
